Edaravone

DRUG12 trials

Sponsors

Ehime University Hospital, Combination Therapy for Acute Ischemic Stroke Study Group, Tanabe Pharma Corporation, Kumamoto University, Zhejiang Hospital

Conditions

Acute Aortic DissectionAlcohol-induced Brain InjuryAmyotrophic Lateral SclerosisBrain NecrosisCerebral InfarctionKidney TransplantationMyocardial InfarctionNasopharyngeal Carcinoma

Phase 1

Autologous Hematopoietic Stem Cell Transplantation in Ischemic Stroke

Zhejiang HospitalStroke

Start: 2012-01-31End: 2013-12-31Target: 40Updated: 2012-01-25

The Safety of Edaravone for patients with Amyotrophic Lateral Sclerosis: Single centered open label trial

Active, not recruitingJPRN-UMIN000016352

Ehime University Hospitalamyotrophic lateral sclerosis

Start: 2015-02-01Target: 10Updated: 2025-07-18

Phase 2

Effect of Edaravone on Radiation-induced Temporal Lobe Necrosis

CompletedNCT01865201

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityBrain Necrosis, Nasopharyngeal Carcinoma

Start: 2009-03-31End: 2012-09-30Updated: 2013-12-12

Treatment Effect of Edaravone in Patients With Amyotrophic Lateral Sclerosis (ALS)

Isfahan University of Medical SciencesNeuromuscular Diseases

Start: 2017-03-16End: 2019-09-16Target: 20Updated: 2019-03-27

Efficacy and Safety of Nerve Growth Factor or Edaravone on Alcohol-induced Brain Injury

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityAlcohol-induced Brain Injury

Start: 2019-06-30End: 2021-12-31Target: 150Updated: 2020-10-27

The Safety and Effectiveness of Cholinergic Receptor Block Therapy in the Treatment of ALS

Ruijin HospitalAmyotrophic Lateral Sclerosis, Respiratory Function, Scopolamine

Start: 2020-11-01End: 2023-10-31Target: 30Updated: 2020-10-14

Phase 4

Edaravone and Argatroban Stroke Therapy Study for Acute Ischemic Stroke

CompletedNCT00153946

Combination Therapy for Acute Ischemic Stroke Study GroupStroke

Start: 2004-08-31End: 2008-05-31Updated: 2008-05-14

Edaravone-Sodium Ozagrel Comparative Post-Marketing Study on Acute Ischemic Stroke

CompletedNCT00200356

Tanabe Pharma CorporationCerebral Infarction

Start: 2004-08-31End: 2006-10-31Updated: 2026-01-07

Pilot Study of Edaravone to Treat Acute Myocardial Infarction

CompletedNCT00265239

Kumamoto UniversityMyocardial Infarction, Reperfusion Injury

Start: 2001-04-30End: 2007-06-30Updated: 2014-09-15

Unknown Phase

Mechanism and Early Intervention Research on ALI During Emergence Surgery of Acute Stanford A Aortic Dissection

Beijing Anzhen HospitalAcute Aortic Dissection

Start: 2013-04-30End: 2015-01-31Target: 220Updated: 2014-01-24

Edaravone on the Ischemia-Reperfusion(I/R) Injury in Kidney Transplantation Patients

Xijing HospitalKidney Transplantation

Start: 2016-03-31End: 2016-10-31Target: 150Updated: 2016-01-01

Edaravone in the Treatment of Optic Neuritis

RecruitingNCT05540262

First Affiliated Hospital of Guangxi Medical UniversityOptic Neuritis

Start: 2022-01-15End: 2025-12-31Target: 50Updated: 2025-02-27

Related Papers

Safety and efficacy of edaravone in well-defined Iranian patients with amyotrophic lateral sclerosis: A parallel-group single-blind trial

Current Journal of Neurology2021-06-147 citations

Oxygenation impairment in patients with acute aortic dissection is associated with disorders of coagulation and fibrinolysis: a prospective observational study.

2019-04-0113 citations

Independent factors related to preoperative acute lung injury in 130 adults undergoing Stanford type-A acute aortic dissection surgery: a single-center cross-sectional clinical study

Journal of Thoracic Disease2018-07-0125 citations

Mechanism and early intervention research on ALI during emergence surgery of Stanford type-A AAD

Medicine2016-10-0112 citations

Effect of edaravone on radiation-induced brain necrosis in patients with nasopharyngeal carcinoma after radiotherapy: a randomized controlled trial.

2014-08-2125 citations